Survey: Feline MCS assessments a missed opportunity for veterinarians?August 16, 2018A recent survey of 111 veterinarians conducted by Kindred Biosciences Inc. found that the majority were not performing feline muscle condition score (MCS) evaluations during physical exams. Body condition scores (BCS) and MCS evaluations are a key part of a complete nutritional assessment for cats, said Christina Fernandez, DVM, MRCVS, DACVECC, professional services veterinarian with Kindred Biosciences. In the survey, 59 percent of veterinarians said they captured BCS during physical exams, but only 14 percent said they perform MCS assessments. "MCS evaluations are a relatively new practice but are increasingly recognized as a best practice in feline care," Dr. Fernandez said. "BCS has been a standard practice for many practitioners, and there are multiple validated scoring systems. Most veterinarians perform a BCS during regular visits, but BCS only evaluates the animal's body fat. MCS evaluations are easy to incorporate into the physical exam and provide extremely valuable information for trending patient body composition status over time. It helps veterinarians watch for any muscle loss over time to ensure our feline patients maintain a healthy body composition — and maybe even offer early warning signs of disease." Muscle loss can be a result of age, illness, and/or injury; no matter …
SPONSORED CONTENTYear-Round Tick Control is ImportantEmpower dog owners to protect their dogs with protection approved by the FDA for the prevention of Lyme infections in dogs as a direct result of killing black-legged ticks. + Learn More
Client checklist: Controlling canine influenza virusAugust 10, 2018With summer underway, plenty of dogs are enjoying fun in the sun with their canine companions, play-fighting and sharing water bowls. Of course, accompanying summer vacation is the increased risk of infectious diseases and other illness. Canine influenza virus (CIV) is at an all-time high this year, with reported cases in at least 46 states. As such, it is more important than ever for veterinarians to warn their clients of some of the tell-tale signs of the illness. Here are some suggestions for helping clients protect their pets from illness year-round, courtesy of Zoetis. Identifying clinical signs Symptoms of CIV are similar to those of other bacterial and viral causes associated with Canine Infectious Respiratory Disease (CIRD). Much like humans, signs of the virus often vary from dog to dog and can last for several weeks. Some symptoms to look out for include: Reduced appetite High fever Cough Runny nose Lethargy Additionally, CIV has no seasonality, so owners should keep an eye out for these symptoms throughout the year; however, it is especially important to keep watch during the summer when dogs tend to spend more time outdoors, socializing with other dogs. Considering treatment options If an owner suspects …
Take Your Cat to the Vet Day gains celebrity supportAugust 8, 2018Veterinarians across the U.S. might see more cats in their clinics in coming weeks, thanks in part to a campaign launched by Royal Canin that is being promoted by actor Ian Somerhalder. Take Your Cat to the Vet Day aims to improve the healthcare of cats across the country by encouraging owners to schedule regular veterinary checkups for their feline companions. The initiative, supported by the American Association of Feline Practitioners, the International Cat Association, CATalyst Council, and the Cat Fanciers' Association, hopes to increase visibility of cats in veterinary clinic by dispelling widespread assumptions about feline health. Research from Royal Canin found 53 percent of owners whose cats have not seen their veterinarian in the past 12 months said they did not take their pet to the clinic because they "did not think it was necessary." However, annual veterinary checkups are vital for early identification and treatment of illness and disease. "Regular feline veterinary care is crucial for the health and happiness of your cat," said Catherine Lenox, DVM, DACVN, Royal Canin scientific affairs manager. "Just like dogs, cats need to see the veterinarian on a regular basis for wellness exams, not only when there's a serious medical need." …
FDA approves sale of Baytril soft chew formulationAugust 6, 2018The U.S. Food and Drug Administration has approved for sale Bayer Animal Health's Baytril Soft Chewable Tablets, based on a soft-chew formulation by Piedmont Animal Health, as a new option for administering enrofloxacin to cats and dogs. The antibiotic has been used for 30 years in tablet form to treat bacteria that cause skin, urinary, respiratory, and other infections. Piedmont's soft chew uses meat-free cubes made without water, heat, or an extrusion process so they can be stably infused with active pharmaceutical ingredients. Bayer also uses Piedmont's soft chew for Advantus canine oral flea medicine and Quellin canine pain reliever and anti-inflammatory. Claro, a single-application treatment for canine otitis externa, gives Bayer four FDA-approved products in the last five years. Piedmont said it will gain FDA approval for 10 or more products in the next five years. "I fully expect that Piedmont's current portfolio of proprietary drugs will significantly grow and disrupt the indication areas we are targeting," said Roland Johnson, the company's founder and CEO. "This (Baytril) approval is yet another stepping stone toward that objective."
WSAVA-endorsed paper encourages healthier breedingAugust 6, 2018The World Small Animal Veterinary Association (WSAVA) has announced its support of a position paper launched in June 2018 by the Federation of Veterinarians of Europe (FVE) and the Federation of European Companion Animal Veterinary Associations (FECAVA). The paper, a response to the explosion in popularity of breeds with exaggerated traits, genetic disorders, and those with extreme brachycephalic conformation, such as French and English bulldogs and pugs, calls for health and welfare to be given priority over looks and offers detailed recommendations to address increased demand for and supply of these dogs. Measures to reduce demand, supply Address demand for brachycephalic and other affected breeds through educating owners about the health issues they face Work with influencers to encourage owners to choose a healthy, high-welfare dog suitable for their lifestyle Introduce the mandatory registration of breeders, prebreeding screening programs, and the sharing of data on conformation-altering surgeries and caesarean sections Educate stakeholders and revising breeding standards and practices to put the health and welfare of dogs first In addition, FVE and FECAVA have produced an infographic that explains the causes and consequences of extreme breeding and lists a number of …
Morris Animal Foundation announces second National Dog Day campaignAugust 3, 2018Since 2004, National Dog Day has been observed on Aug. 26 to encourage dog ownership of mixed-breed and purebred dogs, and to remind us all that canine companions deserve to live long, healthy lives. That's why for the second year in a row, Morris Animal Foundation (MAF) is running a campaign this month through Aug. 26, in which an anonymous donor will match all gifts made to the Golden Retriever Lifetime Study, dollar for dollar, up to $50,000. The $32 million study gathers information on more than 3,000 golden retrievers throughout their lives to identify the nutritional, environmental, lifestyle, and genetic risk factors for cancer and other canine diseases. Its primary goal is to reveal potential risk factors that may lead to the development of four types of cancers common in golden retrievers: hemangiosarcoma, mast cell tumors, lymphoma, and osteosarcoma. Donations can be made to the Golden Retriever Lifetime Study at MAF's website here.
ELIAS presents preliminary canine osteosarcoma results at ACVIMAugust 3, 2018During the 2018 American College of Veterinary Internal Medicine Forum in June, ELIAS Animal Health, a clinical stage development company advancing novel treatments for companion animal cancer, shared preliminary canine osteosarcoma results for its cancer immunotherapy. According to study results presented by Brian Flesner, DVM, DACVIM (Oncology), University of Missouri, the company's new ELIAS autologous cancer vaccine, featuring a patented vaccine and T cell infusion combination approach, demonstrated "impressive survival times and minimal side effects." This cancer immunotherapeutic is being distributed as an experimental product under 9 CFR 103.3 to veterinarians treating dogs diagnosed with cancer. Efficacy and safety have not been established. One in four dogs will be impacted by cancer in their lifetimes, and cancer is the No. 1 cause of death in dogs older than 2. "There has been growing frustration in the veterinary profession with current treatment options, including chemotherapy and radiation, which have only modestly improved outcomes over the past 20 years," said Noe Reyes, DVM, medical director, ELIAS Animal Health. "We are very encouraged by the positive treatment outcomes reported by Dr. Flesner at ACVIM and look forward to starting our pivotal osteosarcoma trial evaluating this T cell-based immunotherapy in a broader population," …
VSMRI offers online forum for rehab, sports medicineAugust 3, 2018The Veterinary Sports Medicine and Rehabilitation Institute (VSMRI) is a new online resource for veterinary health care professionals focused on or interested in the most current information regarding rehabilitation, sports medicine, surgery, and overall care. Content, video, and forum topics include gait analysis, TPLO rehabilitation, the orthopedic examination, and hip dysplasia rehabilitation, surgery and rehabilitation option impacts, and more. The institute said it aims to join veterinary professionals globally from all aspects of veterinary medicine with an interest in physical rehabilitation and sports medicine; provide a library of rehabilitation exercises and modalities, as well as up-to-date research information in the area of rehabilitation and sports medicine; and provide a discussion board and interactive forum. Download VSMRI in the App Store and register at vsmri.com. Charter registration is $14.95/month.
FDA five-year plan to combat rising threat of antibiotic overuseAugust 3, 2018In its ongoing effort to combat antimicrobial resistance, the U.S. Food and Drug Administration (FDA) announced it will implement a five-year blueprint outlining the administration's strategy to "advance antimicrobial stewardship in veterinary settings." As part of the FDA's regulatory mission, its Center for Veterinary Medicine (CVM) is responsible for ensuring the safety and effectiveness of animal drugs, including antimicrobials. Progress has been made, but additional work is needed to address the complex challenge of antimicrobial resistance, the organization said in a statement. "At FDA, we believe that the concept of antimicrobial stewardship encompasses several important principles of judicious use," said FDA Commissioner Scott Gottlieb, MD. "These are critical to slowing the rate at which bacteria develop resistance to antimicrobial drugs. In simple terms, we believe medically important antimicrobial drugs should only be used when necessary to treat, control or prevent disease. In addition, when such use is necessary, these antimicrobials should be used in an optimal manner. They should only be used under the oversight of a licensed veterinarian." The administration's plan, which will cover fiscal years 2019 - 2023, will focus three goals: Aligning antimicrobial drug product use with the principles of antimicrobial stewardship Supporting …
FDA reminds vets of Zycortal Suspension amid Percorten-V shortageAugust 2, 2018Due to a shortage of Percorten-V, which is approved for use as replacement therapy for mineralocorticoid deficit in dogs with Addison's Disease, the U.S. Food and Drug Administration's Center for Veterinary Medicine is reminding veterinarians that Zycortal Suspension is an alternative treatment option that is not currently in shortage. Elanco Animal Health, manufacturer of Percorten-V (desoxycorticosterone pivalate injectable suspension), reported a manufacturing issue with the product. "Elanco is experiencing a delay in production of Percorten-V due to the inability of our contract manufacturing facility to supply product," according to the company's website. "While we work diligently to resolve this delay, there is an interruption of product supply to veterinarians. The technical challenges in the manufacturing process are being actively investigated with a focus on expediting resolution. The timeframe to resume production is dependent on the investigation conclusions and at this point is unknown. Elanco deeply regrets that this production issue is impacting the veterinarians and pets that rely on us to manage this serious disease, and is working persistently to hurry this product back to those who need it." Zycortal Suspension (desoxycorticosterone pivalate injectable suspension), also approved for use replacement therapies for mineralocorticoid …
